Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart
A Phase 1 Evaluation of the Safety and Immunogenicity of a Booster Dose of TV003 Administered 12 Months After Initial Vaccination With TV003
Status: Enrolling
Updated:  12/14/2015
Center for Immunization Research - Johns Hopkins Bloomberg School of Public Health
mi
from
Baltimore, MD
Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart
A Phase 1 Evaluation of the Safety and Immunogenicity of a Booster Dose of TV003 Administered 12 Months After Initial Vaccination With TV003
Status: Enrolling
Updated: 12/14/2015
Center for Immunization Research - Johns Hopkins Bloomberg School of Public Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart
A Phase 1 Evaluation of the Safety and Immunogenicity of a Booster Dose of TV003 Administered 12 Months After Initial Vaccination With TV003
Status: Enrolling
Updated:  12/14/2015
University of Vermont Vaccine Testing Center
mi
from
Burlington, VT
Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart
A Phase 1 Evaluation of the Safety and Immunogenicity of a Booster Dose of TV003 Administered 12 Months After Initial Vaccination With TV003
Status: Enrolling
Updated: 12/14/2015
University of Vermont Vaccine Testing Center
mi
from
Burlington, VT
Click here to add this to my saved trials
Evaluating the Safety and Immune Response to a Dengue Virus Vaccine in Healthy Adults
A Phase 1 Evaluation of the Safety and Immunogenicity of rDEN2Δ30-7169, a Live Attenuated Monovalent Dengue Virus Vaccine
Status: Enrolling
Updated:  12/14/2015
John Hopkins Bloomberg School of Public Health - Center for Immunization Research (CIR)
mi
from
Baltimore, MD
Evaluating the Safety and Immune Response to a Dengue Virus Vaccine in Healthy Adults
A Phase 1 Evaluation of the Safety and Immunogenicity of rDEN2Δ30-7169, a Live Attenuated Monovalent Dengue Virus Vaccine
Status: Enrolling
Updated: 12/14/2015
John Hopkins Bloomberg School of Public Health - Center for Immunization Research (CIR)
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults
A Phase 1 Evaluation of the Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV003 to Protect Against Infection With Attenuated DENV-2, rDEN2∆30-7169
Status: Enrolling
Updated:  12/14/2015
Center for Immunization Research (CIR), Johns Hopkins Bloomberg School of Public Health
mi
from
Baltimore, MD
Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults
A Phase 1 Evaluation of the Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV003 to Protect Against Infection With Attenuated DENV-2, rDEN2∆30-7169
Status: Enrolling
Updated: 12/14/2015
Center for Immunization Research (CIR), Johns Hopkins Bloomberg School of Public Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults
A Phase 1 Evaluation of the Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV003 to Protect Against Infection With Attenuated DENV-2, rDEN2∆30-7169
Status: Enrolling
Updated:  12/14/2015
University of Vermont Vaccine Testing Center
mi
from
Burlington, VT
Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults
A Phase 1 Evaluation of the Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV003 to Protect Against Infection With Attenuated DENV-2, rDEN2∆30-7169
Status: Enrolling
Updated: 12/14/2015
University of Vermont Vaccine Testing Center
mi
from
Burlington, VT
Click here to add this to my saved trials
Respiratory Viral Infections in Pediatric Transplantation
A Multicenter Consortium to Define the Epidemiology and Outcomes of Respiratory Viral Infections in Pediatric Transplant Recipients
Status: Enrolling
Updated:  12/14/2015
Duke University
mi
from
Durham, NC
Respiratory Viral Infections in Pediatric Transplantation
A Multicenter Consortium to Define the Epidemiology and Outcomes of Respiratory Viral Infections in Pediatric Transplant Recipients
Status: Enrolling
Updated: 12/14/2015
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Rapid Detection of Group B Streptococcus (Strep)-Labor and Delivery Study
Rapid Detection of Group B Streptococcus Using a Bedside Microfluidics Device: Labor and Delivery Study
Status: Enrolling
Updated:  12/14/2015
University of Michigan Hospital
mi
from
Ann Arbor, MI
Rapid Detection of Group B Streptococcus (Strep)-Labor and Delivery Study
Rapid Detection of Group B Streptococcus Using a Bedside Microfluidics Device: Labor and Delivery Study
Status: Enrolling
Updated: 12/14/2015
University of Michigan Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection
A Phase 2a, Randomized, Double-blind, Placebo Controlled Study of PRO 140 by Subcutaneous Administration in Adult Subjects With Human Immunodeficiency Virus Type 1 Infection
Status: Enrolling
Updated:  12/14/2015
Progenics Pharmaceuticals, Inc.
mi
from
Tarrytown, NY
Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection
A Phase 2a, Randomized, Double-blind, Placebo Controlled Study of PRO 140 by Subcutaneous Administration in Adult Subjects With Human Immunodeficiency Virus Type 1 Infection
Status: Enrolling
Updated: 12/14/2015
Progenics Pharmaceuticals, Inc.
mi
from
Tarrytown, NY
Click here to add this to my saved trials
Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)
Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and Herpes Simplex Virus 2 (HSV-2) Infection (Phase I)
Status: Enrolling
Updated:  12/15/2015
G.V. (Sonny) Montgomery VA Medical Center, Jackson, MS
mi
from
Jackson, MS
Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)
Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and Herpes Simplex Virus 2 (HSV-2) Infection (Phase I)
Status: Enrolling
Updated: 12/15/2015
G.V. (Sonny) Montgomery VA Medical Center, Jackson, MS
mi
from
Jackson, MS
Click here to add this to my saved trials
Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria
Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria
Status: Enrolling
Updated:  12/16/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria
Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria
Status: Enrolling
Updated: 12/16/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Community - Associated Extended-spectrum Beta-lactamases (ESBL)
Community - Associated Extended-spectrum Beta-lactamases (ESBL)
Status: Enrolling
Updated:  12/16/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Community - Associated Extended-spectrum Beta-lactamases (ESBL)
Community - Associated Extended-spectrum Beta-lactamases (ESBL)
Status: Enrolling
Updated: 12/16/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036)
Pharmacokinetics and Pharmacodynamics of Intravenous Colistin- Pilot Study
Status: Enrolling
Updated:  12/16/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036)
Pharmacokinetics and Pharmacodynamics of Intravenous Colistin- Pilot Study
Status: Enrolling
Updated: 12/16/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation
Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation
Status: Enrolling
Updated:  12/16/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation
Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation
Status: Enrolling
Updated: 12/16/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
University of Arkansas - Arkansas Childrens Hospital
mi
from
Little Rock, AR
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
University of Arkansas - Arkansas Childrens Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Wilmington Hospital Health Center
mi
from
Wilmington, DE
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Wilmington Hospital Health Center
mi
from
Wilmington, DE
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
University of Florida
mi
from
Gainesville, FL
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Children's Memorial Hospital-Northwestern University
mi
from
Chicago, IL
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Children's Memorial Hospital-Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
University of Iowa Hospital
mi
from
Iowa City, IA
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
University of Iowa Hospital
mi
from
Iowa City, IA
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Boston Children's
mi
from
Boston, MA
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Boston Children's
mi
from
Boston, MA
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
University of Michigan
mi
from
Ann Arbor, MI
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
St. Louis University School of Medicine
mi
from
St. Louis, MO
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
St. Louis University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Oak Orchard Community Health Center
mi
from
Brockport, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Oak Orchard Community Health Center
mi
from
Brockport, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Honeoye Falls Family Medicine
mi
from
Honeoye Falls, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Honeoye Falls Family Medicine
mi
from
Honeoye Falls, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Mendon Pediatrics
mi
from
Mendon, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Mendon Pediatrics
mi
from
Mendon, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Long Pond Pediatrics
mi
from
Rochester, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Long Pond Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Goodman Pediatrics
mi
from
Rochester, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Goodman Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Parkway Pediatrics
mi
from
Rochester, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Parkway Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
English Road Pediatrics
mi
from
Rochester, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
English Road Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
12 Corner Pediatrics
mi
from
Rochester, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
12 Corner Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Westside Pediatrics
mi
from
Rochester, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Westside Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Ridgewood Med-Peds
mi
from
Rochester, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Ridgewood Med-Peds
mi
from
Rochester, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Nationwide Children's Hospital
mi
from
Columbus, OH
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Baylor College of Medicine/Texas Children's Hospital
mi
from
Houston, TX
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Baylor College of Medicine/Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
The University of Texas, Houston
mi
from
Houston, TX
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
The University of Texas, Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
University of Washington Medical Center
mi
from
Seattle, WA
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated:  12/17/2015
Baylor College of Medicine - Molecular Virology and Microbiology
mi
from
Houston, TX
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated: 12/17/2015
Baylor College of Medicine - Molecular Virology and Microbiology
mi
from
Houston, TX
Click here to add this to my saved trials
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated:  12/17/2015
Emory Vaccine Center - The Hope Clinic
mi
from
Decatur, GA
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated: 12/17/2015
Emory Vaccine Center - The Hope Clinic
mi
from
Decatur, GA
Click here to add this to my saved trials
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated:  12/17/2015
Saint Louis University - Center for Vaccine Development
mi
from
Saint Louis, MO
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated: 12/17/2015
Saint Louis University - Center for Vaccine Development
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated:  12/17/2015
University of Iowa - Vaccine Research & Education Unit
mi
from
Iowa City, IA
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated: 12/17/2015
University of Iowa - Vaccine Research & Education Unit
mi
from
Iowa City, IA
Click here to add this to my saved trials
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated:  12/17/2015
University of Maryland Medical System - General Clinical Research Center (GCRC)
mi
from
Baltimore, MD
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated: 12/17/2015
University of Maryland Medical System - General Clinical Research Center (GCRC)
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated:  12/17/2015
Group Health Research Institute - Seattle - Vaccines and Infectious Diseases
mi
from
Seattle, WA
Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery
Status: Enrolling
Updated: 12/17/2015
Group Health Research Institute - Seattle - Vaccines and Infectious Diseases
mi
from
Seattle, WA
Click here to add this to my saved trials
Catheter Biofilm Microbiome in Infected Neonatal Catheters.
BIOFILM MICROBIOME AND MICROBIAL DNA LOAD IN NEONATAL CATHETER-ASSOCIATED BLOODSTREAM INFECTIONS
Status: Enrolling
Updated:  12/17/2015
Texas Children's Hospital
mi
from
Houston, TX
Catheter Biofilm Microbiome in Infected Neonatal Catheters.
BIOFILM MICROBIOME AND MICROBIAL DNA LOAD IN NEONATAL CATHETER-ASSOCIATED BLOODSTREAM INFECTIONS
Status: Enrolling
Updated: 12/17/2015
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects
A Phase 1, Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Male and Female Subjects
Status: Enrolling
Updated:  12/17/2015
Clinical Research Facility
mi
from
Lenexa, KA
A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects
A Phase 1, Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Male and Female Subjects
Status: Enrolling
Updated: 12/17/2015
Clinical Research Facility
mi
from
Lenexa, KA
Click here to add this to my saved trials
Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection
Prospective Randomized Double Blind, Placebo-Controlled Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection on 30 Day Recurrence Rates.
Status: Enrolling
Updated:  12/17/2015
Wilford Hall Medical Center
mi
from
Lackland AFB, TX
Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection
Prospective Randomized Double Blind, Placebo-Controlled Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection on 30 Day Recurrence Rates.
Status: Enrolling
Updated: 12/17/2015
Wilford Hall Medical Center
mi
from
Lackland AFB, TX
Click here to add this to my saved trials
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
mi
from
Mobile, AL
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
mi
from
Laguna Hills, CA
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
mi
from
Long Beach, CA
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
mi
from
Sylmar, CA
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
mi
from
Sylmar, CA
Click here to add this to my saved trials
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
mi
from
Ventura, CA
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
mi
from
Ventura, CA
Click here to add this to my saved trials
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
mi
from
Idaho Falls, ID
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
mi
from
Idaho Falls, ID
Click here to add this to my saved trials